UNIVERSAL HEALTH SERVICES INC
For the period ended Dec 31, 2024. Filed Feb 26, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 26, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| UNIVERSAL HEALTH SERVICES, INC. | |
|---|---|
| By: | /s/ MARC D. MILLER |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
| Signatures | Title | Date | |||
| /s/ ALAN B. MILLERAlan B. Miller | Executive Chairman of the Board | February 26, 2025 | |||
|---|---|---|---|---|---|
| /s/ MARC D. MILLERMarc D. Miller | Director, President and Chief Executive Officer (Principal Executive Officer) | February 26, 2025 | |||
| /s/ NINA CHEN-LANGENMAYR | Director | February 26, 2025 | |||
| Nina Chen-Langenmayr | |||||
| /s/ EILEEN C. MCDONNELLEileen C. McDonnell | Director | February 26, 2025 | |||
| /s/ WARREN J. NIMETZWarren J. Nimetz | Director | February 26, 2025 | |||
| /s/ MARIA SINGERMaria Singer | Director | February 26, 2025 | |||
| /s/ ELLIOTT J. SUSSMAN M.D.Elliot J. Sussman M.D. | Director | February 26, 2025 | |||
| /s/ STEVE FILTONSteve Filton | Executive Vice President, Chief Financial Officer and Secretary(Principal Financial and Accounting Officer) | February 26, 2025 | |||
INDEX TO FINANCIAL STATEMENTS
AND FINANCIAL STATEMENT SCHEDULE
| Consolidated Financial Statements: | |
|---|---|
| Report of Independent Registered Public Accounting Firm (PCAOB ID: 238) | 88 |
| Consolidated Statements of Income for December 31, 2024, 2023 and 2022 | 90 |
| Consolidated Statements of Comprehensive Income for December 31, 2024, 2023 and 2022 | 91 |
| Consolidated Balance Sheets as of December 31, 2024 and 2023 | 92 |
| Consolidated Statements of Changes in Equity for December 31, 2024, 2023 and 2022 | 93 |
| Consolidated Statements of Cash Flows for December 31, 2024, 2023 and 2022 | 96 |
| Notes to Consolidated Financial Statements | 97 |
| Supplemental Financial Statement Schedule II: Valuation and Qualifying Accounts as of and for December 31, 2024, 2023, and 2022 | 130 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.